We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHE
8476
DELISTED
Regional Health Properties, Inc.
RHE
$1.72K ﹤0.01%
830
+779
+1,527% +$2.04K
BHM icon
8477
Bluerock Homes Trust
BHM
$37M
$1.72K ﹤0.01%
98
-400
-80% -$6.83K
TISI icon
8478
Team
TISI
$77.4M
$1.71K ﹤0.01%
193
+153
+383% +$1.17K
MLPD
8479
Global X MLP & Energy Infrastructure Covered Call ETF
MLPD
$30.9M
$1.71K ﹤0.01%
+68
New +$1.7K
APYX icon
8480
Apyx Medical
APYX
$181M
$1.71K ﹤0.01%
1,273
+769
+153% +$1.13K
LNZAW icon
8481
LanzaTech Global Warrant
LNZAW
$2.96M
$1.71K ﹤0.01%
8,972
+8,793
+4,912% +$1.91K
RUMBW
8482
RUM Group Inc Warrant
RUMBW
$12.9M
$1.7K ﹤0.01%
+1,621
New +$2.55K
SONDW
8483
DELISTED
Sonder Holdings Inc Warrants
SONDW
$1.7K ﹤0.01%
169,622
-2,654
-2% -$27
DIVS icon
8484
Guinness Atkinson Dividend Builder ETF
DIVS
$41.1M
$1.7K ﹤0.01%
61
-25
-29% -$683
IMVP
8485
Invesco India ETF
IMVP
$114M
$1.7K ﹤0.01%
58
-406
-88% -$11.2K
TSLH
8486
DELISTED
Innovator Hedged TSLA Strategy ETF
TSLH
$1.7K ﹤0.01%
66
-20
-23% -$466
PHIO icon
8487
Phio Pharmaceuticals
PHIO
$12M
$1.69K ﹤0.01%
272
+121
+80% +$791
BLCV icon
8488
BlackRock Large Cap Value ETF
BLCV
$349M
$1.68K ﹤0.01%
55
-16
-23% -$492
GTR icon
8489
WisdomTree Target Range Fund
GTR
$71.9M
$1.68K ﹤0.01%
70
-44
-39% -$1.04K
EPR.PRE icon
8490
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$114M
$1.67K ﹤0.01%
60
-871
-94% -$24.1K
DECA
8491
DELISTED
Denali Capital Acquisition Corp. Class A Ordinary Shares
DECA
$1.67K ﹤0.01%
+149
New +$1.15K
FUSB icon
8492
First US Bancshares
FUSB
$92.1M
$1.67K ﹤0.01%
+180
New +$1.81K
OPTN
8493
DELISTED
OptiNose
OPTN
$1.66K ﹤0.01%
107
-4,776
-98% -$80K
CHMI
8494
Cherry Hill Mortgage Investment Corp
CHMI
$84.9M
$1.66K ﹤0.01%
457
ISTM
8495
iShares Strategic Metals ETF
ISTM
$29.5M
$1.65K ﹤0.01%
+58
New +$1.68K
VNSE icon
8496
Natixis Vaughan Nelson Select ETF
VNSE
$14.2M
$1.64K ﹤0.01%
50
+2
+4% +$65
MARZ icon
8497
TrueShares Structured Outcome March ETF
MARZ
$32.9M
$1.64K ﹤0.01%
53
-14
-21% -$421
AMST icon
8498
Amesite
AMST
$6.81M
$1.64K ﹤0.01%
547
-1,317
-71% -$3.93K
WBND
8499
DELISTED
Western Asset Total Return ETF
WBND
$1.64K ﹤0.01%
82
-1,609
-95% -$31.9K
EMCS
8500
Xtrackers MSCI Emerging Markets Select ETF
EMCS
$987M
$1.63K ﹤0.01%
+63
New +$1.58K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.